Kristoffer Famm


Kris is president of Galvani Bioelectronics, being overall responsible for the company’s path to and delivery of bioelectronic medicines to patients. Before his appointment to lead Galvani Bioelectronics, he was founding VP and head of Bioelectronics R&D at GSK, which he launched in 2013. There he managed the unit’s extensive research towards establishing the treatment potential, disease reach and technology requirements for modulating signal patterns in visceral, peripheral nerves. He led the way in how we address these challenges on a global scale, too, working together with a network of research partners across academia and industry.

During his time at GSK he also headed up the R&D Strategy Group and the Protein Degradation Discovery Performance Unit.

Kris obtained his PhD in Molecular Biology at University of Cambridge, following an MSc in Chemical Engineering at Lund University, Sweden. Before joining GSK in 2009, he worked as a management consultant at McKinsey & Co.